You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 13, 2024

Details for Patent: 11,311,486


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 11,311,486 protect, and when does it expire?

Patent 11,311,486 protects EXPAREL and is included in one NDA.

This patent has eight patent family members in four countries.

Summary for Patent: 11,311,486
Title:Manufacturing of bupivacaine multivesicular liposomes
Abstract: Embodiments of the present application relate to commercial manufacturing processes for making bupivacaine multivesicular liposomes (MVLs) using independently operating dual tangential flow filtration modules.
Inventor(s): Hall; Jeffrey S. (San Diego, CA), Turnbull; David J. (San Diego, CA), Grigsby, Jr.; John J. (San Diego, CA), Ardekani; Soroush M. (San Diego, CA), Davis; Paige N. (San Diego, CA), Garcia; Louie D. (San Diego, CA), Kurz; Stephanie M. (San Diego, CA), Los; Kathleen D. A. (San Diego, CA)
Assignee: Pacira Pharmaceuticals, Inc. (San Diego, CA)
Application Number:17/536,478
Patent Claim Types:
see list of patent claims
Use; Composition; Formulation; Dosage form;

Drugs Protected by US Patent 11,311,486

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Pacira Pharms Inc EXPAREL bupivacaine INJECTABLE, LIPOSOMAL;INJECTION 022496-001 Oct 28, 2011 AP RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y METHOD OF TREATING PAIN, FOR EXAMPLE, TREATING POSTSURGICAL PAIN VIA INFILTRATION FOR LOCAL ANALGESIA OR VIA INTERSCALENE BRACHIAL PLEXUS NERVE BLOCK FOR REGIONAL ANALGESIA ⤷  Sign Up
Pacira Pharms Inc EXPAREL bupivacaine INJECTABLE, LIPOSOMAL;INJECTION 022496-002 Oct 28, 2011 AP RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y METHOD OF TREATING PAIN, FOR EXAMPLE, TREATING POSTSURGICAL PAIN VIA INFILTRATION FOR LOCAL ANALGESIA OR VIA INTERSCALENE BRACHIAL PLEXUS NERVE BLOCK FOR REGIONAL ANALGESIA ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 11,311,486

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
China 114209654 ⤷  Sign Up
European Patent Office 4032528 ⤷  Sign Up
United Kingdom 202200778 ⤷  Sign Up
United Kingdom 202312422 ⤷  Sign Up
United Kingdom 202404737 ⤷  Sign Up
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.